Skip to main content
. Author manuscript; available in PMC: 2010 Jan 12.
Published in final edited form as: N Engl J Med. 2009 Oct 1;361(14):1339–1348. doi: 10.1056/NEJMoa0902430

Table 2.

Primary Perinatal Outcome.*

Outcome Variable Treatment Group (N = 485) Control Group (N = 473) Relative Risk (97% CI) P Value
Gestational age at birth — wk 39.0±1.8 38.9±1.8 0.87
Composite end point — no./total no. (%) 149/460 (32.4) 163/440 (37.0) 0.87 (0.72–1.07) 0.14
 Hypoglycemia 62/381 (16.3) 55/357 (15.4) 1.06 (0.73–1.53) 0.75
 Hyperbilirubinemia 43/450 (9.6) 54/418 (12.9) 0.74 (0.49–1.12) 0.12
 Elevated cord-blood C-peptide level 75/423 (17.7) 92/403 (22.8) 0.78 (0.57–1.05) 0.07
 Stillbirth or neonatal death 0 0
 Birth trauma§ 3/476 (0.6) 6/455 (1.3) 0.48 (0.10–2.20) 0.33
*

Plus–minus values are means ± SD.

The composite perinatal outcome included stillbirth, neonatal death, hypoglycemia, hyperbilirubinemia, elevated cord-blood C-peptide level, and birth trauma.

The results of some blood tests were not available either because samples were not obtained or were not obtained according to protocol or because they could not be assayed owing to a laboratory processing error.

§

Data were not available in some cases because some women delivered at outside institutions.